MET and breast carcinoma: Consistently, T-47D breast cancer cells without detectable c-Met protein expression were markedly less sensitive (> 10-fold) to the antiproliferative effects of HVS compared to those expressing c-Met, confirming the differential sensitivity to c-Met-dependent human breast cancer cells.